Hemostemix Inc. (TSXV:HEM)
Canada · Delayed Price · Currency is CAD 0.0650
0.00 (0.00%)
Jul 21, 2026, 9:42 AM EST
Hemostemix Market Cap
Hemostemix has a market cap or net worth of CAD 12.86 million as of July 21, 2026. Its market cap has decreased by -37.10% in one year.
Market Cap
12.86M
Enterprise Value
16.16M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
ChartMarket Cap Chart
Since November 28, 2014, Hemostemix's market cap has decreased from 48.88M to 12.86M, a decrease of -73.69%. That is a compound annual growth rate of -10.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 12.86M | -26.83% |
| Dec 31, 2025 | 17.57M | 3.39% |
| Dec 31, 2024 | 17.00M | 178.71% |
| Dec 29, 2023 | 6.10M | -55.27% |
| Dec 30, 2022 | 13.63M | 44.06% |
| Dec 31, 2021 | 9.46M | -70.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quantum BioPharma | 28.79M |
| Lobe Sciences | 28.41M |
| Sharp Therapeutics | 27.37M |
| Alzai Health | 25.02M |
| Devonian Health Group | 19.49M |
| Pharmala Biotech Holdings | 16.33M |
| Rapid Dose Therapeutics | 15.01M |
| Britannia Life Sciences | 11.36M |